Psychometric properties of the ICECAP-SCM capability-wellbeing measure in specialist palliative care units in Austria
Saly E. et al, (2025), Quality of Life Research
Stereotactic radiotherapy for nAMD: areas for improvement - Authors' reply.
Jackson TL. et al, (2025), Lancet, 406, 26 - 27
Non-mental health inpatient and emergency care hospital costs associated with four mental disorders in Europe: a modelling study
Wienand D. et al, (2025), Lancet Psychiatry, 12, 513 - 523
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK.
Browning M. et al, (2025), Lancet Psychiatry
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial
Zhou J. et al, (2025), EClinicalMedicine
Does the Risk Premium Differ Between Women Engaging in Commercial and Transactional Sex? Evidence From Urban Cameroon.
Njuguna RG. et al, (2025), Health Econ
Preferences for multi-cancer tests (MCTs) in primary care: discrete choice experiments of general practitioners and the general public in England
Buckell J. et al, (2025), British Journal of Cancer
Implementation of Delirium Screening at Scale in Older Patients With Emergency Hospital Admission.
Boucher EL. et al, (2025), JAMA Intern Med
Healthcare professionals' perspectives on assessing selected patient-reported outcome measures in specialist palliative care institutions: a multi-country mixed-methods study.
Saly E. et al, (2025), BMC Palliat Care, 24
The Use of EQ-5D in the Middle East and North Africa Region: A Systematic Literature Review.
Al Rabayah A. et al, (2025), Pharmacoeconomics
The Value of Hope in Cancer Care: Risk Preference and Heterogeneity in Cancer Patients and the General Public.
Hong J. et al, (2025), Value Health
Distributional cost-effectiveness analysis in genomic medicine: Considerations for addressing health equity.
Smith HS. et al, (2025), Value Health
Cancer inequalities in the United Kingdom and the data used to measure them: a scoping review.
Underwood S. et al, (2025), Lancet Reg Health Eur, 52
Clinical and cost-effectiveness of detailed anomaly ultrasound screening in the first trimester: a mixed-methods study.
Karim JN. et al, (2025), Health Technol Assess, 29, 1 - 250
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.
McAllister-Williams H. et al, (2025), Health Technol Assess, 29, 1 - 216